Booth No.4U-24
CategoryIngredients
Mithra Biotechnology Inc.
Booth No.：4U-24
Category：Ingredients
Company Information
Email：
yrchen@mithracro.com
TEL： +886-2-2696-2669
Address： 7F, No.104, Sec.1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221411, Taiwan R.O.C. TAIWAN
URL：
http://www.mithracro.com
Contact in Japan
Japan agent： LibraMedicina Inc.
Email：
imanishi@lmed.co.jp
TEL： +81-3-6712-7668
Address： Nihonbashi Life Science Bldg. No. 2, Room 704 3-11-5, Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, Japan
Mithra Biotechnology, the first CRO in Taiwan, offers integrated and multi-dimensional CRO services including bioanalytical services for chemical drugs and biologics, full characterization plans for biologics, bioavailability/bioequivalence (BA/BE) studies, and early phase clinical trials to facilitate pharmaceutical development. The company has proven expertise and experience in meeting international standards to serve the fast growing pharmaceutical industry.
Company information
| Address | 7F, No.104, Sec.1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221411, Taiwan R.O.C. TAIWAN |
|---|---|
| TEL | +886-2-2696-2669 |
| FAX | +886-2-2696-2543 |
| URL | http://www.mithracro.com |
| yrchen@mithracro.com |
| Product Classification |
Bioavailability & Bioequivalence Study Clinical Trials Biopharmaceutical Analysis Preclinical & Clinical Bioanalysis Clinical Site Management Pharmacokinetics Study Phase I - First in Human Clinical Study Clinical Operation Non-NCE Drug Development-505(b)(2) pathway Food Effect Study / Drug-Drug-Interaction PK/PD Modeling Lab Manual/Lab Kit Development Immunogenicity Assessment Biomarker Analysis Cytokine Analysis Antibody Drug Conjugate (ADC) Analysis Biosimilar Development Protein Characterization API Analysis Impurity Analysis |
|---|
Contact in Japan
| Japan Agent | LibraMedicina Inc. |
|---|---|
| Address | Nihonbashi Life Science Bldg. No. 2, Room 704 3-11-5, Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, Japan |
| TEL | +81-3-6712-7668 |
| FAX | +81-3-6712-7669 |
| imanishi@lmed.co.jp |